No Data
Weigao Orthopedics (688161.SH) has spent 69.962 million yuan to repurchase 2.2311 million shares.
Weigao Orthopedic (688161.SH) announced that as of July 31, 2024, the company has successfully passed the preliminary review and on-site audit of listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange (SSE).
Some Confidence Is Lacking In Shandong Weigao Orthopaedic Device Co., Ltd's (SHSE:688161) P/S
Weigao Group (01066): Weigao Orthopedics will distribute a cash dividend of 0.12048 yuan per share on July 5th.
Weigao Group (01066) announced that Weigao Orthopedics will distribute a cash dividend of 0.12048 yuan per share on July 5, 2024.
Weigao Orthopedics (688161.SH): Has repurchased 0.399% of the company's shares.
Weigao Orthopedics (688161.SH) announced that as of June 30, 2024, the company has accumulated the repurchase of 1,597,266 shares through the Shanghai Stock Exchange trading system through centralized competitive transactions, accounting for 0.399% of the total share capital of the company, with the highest repurchase price of 42.40 yuan per share, the lowest price of 28.59 yuan per share, and a total amount of CNY 57,460,342.24 (excluding transaction fees).
Weigao Orthopedics (688161.SH) will distribute 0.12048 yuan per share in 2023, with a record date of July 4th.
Weigao Orthopedics (688161.SH) announced that the company will implement annual equity distribution in 2023, with a distribution of... per share.
Shandong Weigao Orthopedic Materials Co., Ltd.'s 2023 Annual Report (Revised Edition)
The Returns On Capital At Shandong Weigao Orthopaedic Device (SHSE:688161) Don't Inspire ConfidenceNo Data
